144 related articles for article (PubMed ID: 15916459)
1. Managing cardiovascular risk factors: the gap between evidence and practice.
Turnbull F
PLoS Med; 2005 May; 2(5):e131. PubMed ID: 15916459
[TBL] [Abstract][Full Text] [Related]
2. Evidence-based prescribing: combining network meta-analysis with multicriteria decision analysis to choose among multiple drugs.
Naci H; van Valkenhoef G; Higgins JP; Fleurence R; Ades AE
Circ Cardiovasc Qual Outcomes; 2014 Sep; 7(5):787-92. PubMed ID: 25097214
[No Abstract] [Full Text] [Related]
3. Prescribing Statins to Reduce Cardiovascular Disease: 10 Common Misconceptions.
Schade DS; Shey L; Eaton RP
Am J Med; 2019 Aug; 132(8):897-899. PubMed ID: 30851261
[No Abstract] [Full Text] [Related]
4. Miracle or mirage?
Learner S
Nurs Stand; 2007 Aug 1-7; 21(47):18-20. PubMed ID: 17824448
[TBL] [Abstract][Full Text] [Related]
5. Why are statin prescribing guidelines for primary prevention not always followed in primary care?
Hassan Y; Ford J; Steel N; Sheldon J; Fleetcroft R
Br J Gen Pract; 2016 Oct; 66(651):536-7. PubMed ID: 27688515
[No Abstract] [Full Text] [Related]
6. Does use of pooled cohort risk score overestimate the use of statin?: a retrospective cohort study in a primary care setting.
Chia YC; Lim HM; Ching SM
BMC Fam Pract; 2014 Nov; 15():172. PubMed ID: 25388219
[TBL] [Abstract][Full Text] [Related]
7. Statins and safety: applying the results of randomized trials to clinical practice.
Waters D
Am J Cardiol; 2003 Sep; 92(6):692-5. PubMed ID: 12972108
[No Abstract] [Full Text] [Related]
8. Assessment of Primary Care Appointment Times and Appropriate Prescribing of Statins for At-Risk Patients.
Hare AJ; Adusumalli S; Park S; Patel MS
JAMA Netw Open; 2021 May; 4(5):e219050. PubMed ID: 33974057
[TBL] [Abstract][Full Text] [Related]
9. Inequality in provision of medical care in Sweden: a case of social epidemiological hypochondria?
Kaufman JS
J Epidemiol Community Health; 2010 Aug; 64(8):651-2. PubMed ID: 20670974
[No Abstract] [Full Text] [Related]
10. Does clinician-reported lipid guideline adoption translate to guideline-adherent care? An evaluation of the Patient and Provider Assessment of Lipid Management (PALM) registry.
Lowenstern A; Li S; Navar AM; Virani S; Lee LV; Louie MJ; Peterson ED; Wang TY
Am Heart J; 2018 Jun; 200():118-124. PubMed ID: 29898839
[TBL] [Abstract][Full Text] [Related]
11. Prescribing statins in general practice: who decides?
Steel N; Fleetcroft B; Hassan Y
Br J Gen Pract; 2017 Jun; 67(659):246-247. PubMed ID: 28546390
[No Abstract] [Full Text] [Related]
12. Perceptions of Canadian vascular surgeons toward pharmacological risk reduction in patients with peripheral arterial disease.
Al-Omran M; Lindsay TF; Major J; Jawas A; Leiter LA; Verma S;
Ann Vasc Surg; 2006 Sep; 20(5):555-63. PubMed ID: 16871436
[TBL] [Abstract][Full Text] [Related]
13. Statins in the elderly: what evidence of their benefit in prevention?
Steg PG; Tissot CM
Arch Cardiovasc Dis; 2010 Feb; 103(2):61-5. PubMed ID: 20226424
[No Abstract] [Full Text] [Related]
14. [Statins: from data to routine prescription…].
Vital Durand D
Rev Med Interne; 2014 Mar; 35(3):151-3. PubMed ID: 24314846
[No Abstract] [Full Text] [Related]
15. Update on statins and other lipid-lowering drugs.
Miller CA
Geriatr Nurs; 2001; 22(5):276-7. PubMed ID: 11606910
[No Abstract] [Full Text] [Related]
16. Implementation of the 2013 American College of Cardiology/American Heart Association Blood Cholesterol Guideline Including Data From the Improved Reduction of Outcomes: Vytorin Efficacy International Trial.
Ziaeian B; Dinkler J; Watson K
Rev Cardiovasc Med; 2015; 16(2):125-30. PubMed ID: 26198559
[TBL] [Abstract][Full Text] [Related]
17. Appropriate clinical use of statins: a discussion of the evidence, scope, benefits, and risk.
Perlmutter D; Golomb B; Sinatra S; Campbell AW
Altern Ther Health Med; 2013; 19 Suppl 1():14-25. PubMed ID: 23981463
[No Abstract] [Full Text] [Related]
18. Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosis.
Brown LC; Johnson JA; Majumdar SR; Tsuyuki RT; McAlister FA
CMAJ; 2004 Nov; 171(10):1189-92. PubMed ID: 15534311
[TBL] [Abstract][Full Text] [Related]
19. Management of Severe and Moderate Hypercholesterolemia in Young Women and Men.
Newton SL; Hoffmann AP; Yu Z; Haidermota S; Natarajan P; Honigberg MC
JAMA Cardiol; 2022 Feb; 7(2):227-230. PubMed ID: 34780599
[TBL] [Abstract][Full Text] [Related]
20. Sex-specific-differences in cardiometabolic risk in type 1 diabetes: a cross-sectional study.
Kautzky-Willer A; Stich K; Hintersteiner J; Kautzky A; Kamyar MR; Saukel J; Johnson J; Lemmens-Gruber R
Cardiovasc Diabetol; 2013 May; 12():78. PubMed ID: 23705959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
